Science at a Premium

Although research supplies are exempted from Argentina’s import restrictions, regulations for bringing materials into the country are hampering science nonetheless.

Written byKerry Grens
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, SERGIO ANDRES SEGOVIAAt the height of the Argentine summer this year, stores in the South American country were running out of tampons. Scarcity of such a product—one many assume would be on the shelves of any corner store—was but one example of the unintended consequences of an economic policy put into place four years ago. And while these regulations are meant to protect scientists, by carving out exemptions for laboratory supplies, some researchers in Argentina are struggling to get the basic supplies they rely on to do their experiments.

In 2011, as part of an effort to right the foundering economy of Argentina and keep pesos within its borders, officials imposed strict restrictions on importing goods from outside the country. The Ministry of Science, Technology, and Productive Innovation “has its own special channels to arrange research equipment and supplies imports,” press officer Hernán Bongioanni wrote to The Scientist in an e-mail, “therefore there is no impact of import restrictions for the Argentinian scientific community.”

While scientists are technically able to order supplies from abroad without the taxes and limitations tacked onto consumer goods, in a practical sense, the customs regulations have had a very real and negative impact on research.

“With the restrictions the importers are not importing things very fast. Sometimes it takes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies